Douin, David J.
Wogu, Adane F.
Beaty, Laurel E.
Carlson, Nichole E.
Bennett, Tellen D.
Aggarwal, Neil R.
Mayer, David A.
Ong, Toan C.
Russell, Seth
Steele, Jeffrey
Peers, Jennifer L.
Molina, Kyle C.
Wynia, Matthew K.
Ginde, Adit A.
Funding for this research was provided by:
National Center for Advancing Translational Sciences (UL1TR002535)
Article History
Received: 4 April 2022
Accepted: 27 October 2022
First Online: 7 November 2022
Declarations
:
: All methods were performed in accordance with the Declaration of Helsinki and were approved by the Colorado Multiple Institutional Review Board (COMIRB) with a waiver of informed consent.
: Not applicable.
: Dr. Douin received research grant funding from the NIH / National Institute of General Medical Sciences (NIGMS) T32GM135169. Dr. Ginde received other Covid-19 research grants from NIH, DoD, CDC, AbbVie, and Faron Pharmaceuticals, outside the current work. Dr. Wynia received research funding from PCORI and ASPR and is an unpaid advisor to NASEM, including on crisis standards of care during the Covid-19 pandemic, and to DARPA, the Hastings Center, and the Lancet on projects unrelated to mAbs. Dr. Bennett, Dr. Aggarwal, and Dr. Carlson received research grants from the NIH outside of the current work. Other authors have no disclosures to report.